Polaprezinc
่ๆฎ็้
Report date: 2023/03/14 11:07:47
NME
Base Information
Drug NamePolaprezinc
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]ย
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1994/10/03
Country/Territory +[4]ย
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZeria
China Registration ClassN/A
Develop Information
Active CompaniesNational Institutes Of HealthUniversity Of LouisvilleNational Heart, Lung, And Blood Institute (Nhlbi) +[6]ย
Inactive CompaniesGeorgetown UniversityUniversity Of MilanSichuan Beida'Er New Technology Development Co Ltd
Active Indications
Inactive Indications